SpringerLink
Log in

Ortho-vanillin nanoparticle-doped glucan microspheres exacerbate the anti-arthritic effects of methotrexate in adjuvant-induced arthritis in rats

  • Article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

Methotrexate (MTX) commonly used in rheumatoid arthritis (RA) has severe adverse effects. Ortho-vanillin, an inhibitor of Toll-like receptors (TLR), can prevent inflammation. Glucan is a cereal fiber recognized by dectin-1 or β-glucan receptors of phagocytic macrophages. The purpose of the current project was to study the effect of co-administration of MTX and vanillin by targeted delivery to macrophages using β-glucan microspheres to reduce inflammation of RA.

Methods

MTX and vanillin nanoparticles in bovine serum albumin (BSA) or gelatin were doped in glucan particles (GPs) and characterized for their physical properties. Twenty-four hours after induction of RA in paw of rats, they received normal saline (1 mg/kg, ip), MTX (2 mg/kg/week, ip), β-glucan (1 mg/kg/week, ip), GPs-MTX (2 mg/kg/week, ip), GPs-vanillin (200 mg/kg/day, po), and GPs-MTX (2 mg/kg/week, ip) plus GPs-vanillin (200 mg/kg/day, po). The last group received free MTX ip and vanillin po for 14 days. Then, joint diameters, TNF-α and IL-6, were evaluated in rats.

Results

The particle size of the GPs was 5.3 µm. MTX loading efficiency in glucan microspheres was 64.5% and vanillin 44.2%. The microspheres released 88.7% of MTX and 95.1% of vanillin over 24 h. The results of in vivo studies showed a significant reduction in paw volume, TNF-α and IL-6 (p < 0.05) in animals treated with combination of MTX and vanillin-doped glucan microspheres compared to the mixture of the two drugs in free form or each drug alone.

Conclusions

Co-administration of MTX and vanillin-doped GPs may be more effective than MTX alone in RA.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778–99.

    Article  CAS  PubMed  Google Scholar 

  2. Rajagopalan PR, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG. Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics. Proc Natl Acad Sci. 2002;99(21):13481–6.

    Article  CAS  PubMed  Google Scholar 

  3. Wessels J, Huizinga T, Guchelaar H-J. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology. 2008;47(3):249–55.

    Article  CAS  PubMed  Google Scholar 

  4. Brody M, Böhm I, Bauer R. Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1β to the interleukin 1 receptor on target cells. Clin Chem Lab Med. 1993;31(10):667–74.

    Article  CAS  Google Scholar 

  5. Weisman MH, Furst DE, Park GS, Kremer JM, Smith KM, Wallace DJ, et al. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. Arthritis Rheum. 2006;54(2):607–12.

    Article  CAS  PubMed  Google Scholar 

  6. To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y, et al. Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int. 2011;28(3):267–74.

    Article  CAS  PubMed  Google Scholar 

  7. Cronstein BN, Naime D, Ostad E. The anti-inflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993;92(6):2675.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Tekeoglu I, Dogan A, Ediz L, Budancamanak M, Demirel A. Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models. Phytother Res. 2007;21(9):895–7.

    Article  CAS  PubMed  Google Scholar 

  9. Barich LL, Schwarz J, Barich D. Oral methotrexate in mice: a co-carcinogenic as well as an anti-tumor agent to methylcholanthrene-induced cutaneous tumors. J Invest Dermatol. 1962;39(6):615–20.

    Article  CAS  Google Scholar 

  10. Yang L, Zhang J, Wang G. The effect of sodium hyaluronate treating knee osteoarthritis on synovial fluid interleukin-1β and clinical treatment mechanism. Pak J Pharm Sci. 2015;28(1):407–10.

    CAS  PubMed  Google Scholar 

  11. Baici A, Lang A, Hörler D, Kissling R, Merlin C. Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage. Ann Rheum Dis. 1995;54(4):289–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Feng Z, Lian K. Identification of genes and pathways associated with osteoarthritis by bioinformatics analyses. Eur Rev Med Pharmacol Sci. 2015;19(5):736–44.

    CAS  PubMed  Google Scholar 

  13. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007;204(12):2803–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Andreakos E, Sacre S, Foxwell BM, Feldmann M. The toll-like receptor-nuclear factor _B pathway in rheumatoid arthritis. Front Biosci. 2005;10:2478–88.

    Article  CAS  PubMed  Google Scholar 

  15. Brentano F, Kyburz D, Schorr O, Gay R, Gay S. The role of Toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol. 2005;233:90–6.

    Article  CAS  PubMed  Google Scholar 

  16. Seibl R, Kyburz D, Lauener RP, Gay S. Pattern recognition receptors and their involvement in the pathogenesis of arthritis. Curr Opin Rheumatol. 2004;16:411–8.

    Article  PubMed  Google Scholar 

  17. Feldmann M, Maini RN. Anti-TNF therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol. 2001;19:163–96.

    Article  CAS  PubMed  Google Scholar 

  18. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1–14.

    Article  CAS  PubMed  Google Scholar 

  19. Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol. 2003;162:1221–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. De Rycke L, Vandooren B, Kruithof E, De Keyser F, Veys EM, Baeten D. Tumor necrosis factor blockade treatment downmodulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. Arthritis Rheum. 2005;52:2146–58.

    Article  PubMed  Google Scholar 

  21. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, et al. Expression of Toll-like receptor 2 on CD16_ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2004;50:1457–67.

    Article  CAS  PubMed  Google Scholar 

  22. Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, Barrera P, et al. Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon. Arthritis Rheum. 2004;50:3856–65.

    Article  CAS  PubMed  Google Scholar 

  23. Mistry P, Laird MH, Schwarz RS, Greene S, Dyson T, Snyder GA, et al. Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain. Proc Natl Acad Sci USA. 2015;112(17):5455–60.

    Article  CAS  PubMed  Google Scholar 

  24. Soto ER, Ostroff GR. Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery. Bioconjug Chem. 2008;19(4):840–8.

    Article  CAS  PubMed  Google Scholar 

  25. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, et al. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol. 2004;173(2):797–806.

    Article  CAS  PubMed  Google Scholar 

  26. Huang H, Ostroff GR, Lee CK, Wang JP, Specht CA, Levitz SM. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and Toll-like receptor agonists. Infect Immun. 2009;77(5):1774–811.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol. 2004;40(12):869–76.

    Article  CAS  PubMed  Google Scholar 

  28. Figueiredo S, Moreira J, Geraldes CG, Rizzitelli S, Aimeb S, Terreno E. Yeast cell wall particles: a promising class of nature-inspired microcarriers for multimodal imaging. Chem Commun. 2011;47(38):10635–7.

    Article  CAS  Google Scholar 

  29. Soto ER, Kim YS, Lee J, Kornfeld H, Ostroff GR. Glucan particle encapsulated rifampicin for targeted delivery to macrophages. Polymers. 2010;2(4):681–9.

    Article  CAS  Google Scholar 

  30. Huang H, Ostroff GR, Lee CK, Agarwal S, Ram S, Rice PA, et al. Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans. J Immunol. 2012;189(1):312–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Smet RD, Demoor T, Verschuere S, Dullaers M, Ostroff GR, Leclercq G, et al. β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination. J Control Release. 2013;172(3):671–8.

    Article  PubMed  Google Scholar 

  32. Yu M, Chen Z, Guo W, Wang J, Feng Y, Kong X, et al. Specifically targeted delivery of protein to phagocytic macrophages. Int J Nanomedicine. 2015;10:1743–57.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Leo E, Vandelli MA, Cameroni R, Forni F. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process. Int J Pharm. 1997;155(1):75–82.

    Article  CAS  Google Scholar 

  34. Willmott N, Cummings J, Florence AT. In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres. J Microencapsul. 1985;2:293–304.

    Article  CAS  PubMed  Google Scholar 

  35. Yu Z, Yu M, Zhang Z, Hong G, **ong Q. Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear. Nanoscale Res Lett. 2014;9(1):343.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R, et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine. 2010;5:669–77.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Novel Drug Delivery Systems Research Centre, Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, PO Box 81745-359, Isfahan, Iran

    Shiva Nasr & Jaleh Varshosaz

  2. Department of Pharmacology and Toxicology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran

    Valiolah Hajhashemi

Authors
  1. Shiva Nasr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaleh Varshosaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valiolah Hajhashemi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaleh Varshosaz.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nasr, S., Varshosaz, J. & Hajhashemi, V. Ortho-vanillin nanoparticle-doped glucan microspheres exacerbate the anti-arthritic effects of methotrexate in adjuvant-induced arthritis in rats. Pharmacol. Rep 72, 680–691 (2020). https://doi.org/10.1007/s43440-020-00099-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43440-020-00099-x

Keywords

Search

Navigation